| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Capecitabine |
|---|
| Description | A pre-prodrug of 5-fluorouracil (5-FU). After oral uptake, capecitabine is first metabolized to 5'-deoxy-5-fluorocytidine (5'-DFCR), which occurs mainly in the liver by carboxyl-esterase. The metabolite is converted to 5'-deoxy-5-fluoro-uridine (5'-DFUR) by cytidine deaminase in liver and tumor tissue. Then 5'-DFUR is converted to 5-FU intracellularly by thymidine phosphorylase, which is often expressed in tumor tissue. MW: 359.35. Purity ≥99% by HPLC |
|---|
| Size | 1 g |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Pentyl[1-(3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)- 5-fluoro-2-oxo-1H-pyrimidin- 4-yl]aminomethanoate; captabin; Ro 09-1978; Xabine |
|---|
| Gene, Accession, CAS # | CAS: 154361-50-9 |
|---|
| Catalog # | 1741-1000 |
|---|
| Price | |
|---|
| Order / More Info | Capecitabine from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|